BURLINGTON, Mass., Jan. 2, 2014 (GLOBE NEWSWIRE) -- LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of peripheral vascular devices and implants, announced today that it has begun selling Direct-to-Hospital in Australia and Norway in January 2014.

"Geographic expansion continues to fuel our growth. With the addition of Australia and Norway, we now sell directly to hospitals in 19 of the 25 highest GDP per capita countries. Being direct in so many countries allows us to better serve our vascular surgeon customers," said George W. LeMaitre, Chairman and CEO.

To prepare for the go-direct initiative in Australia, the Company appointed a country manager in Q3 2013 and opened an office in Melbourne in Q4 2013. The Company hired two Australian sales reps in December 2013, and on January 1, 2014, it transitioned all Australian customer relationships from its previous distributor.

The Company also hired its first Norwegian sales rep in December 2013, and transitioned all Norwegian customer relationships from its previous distributor on January 1, 2014.

About LeMaitre Vascular

LeMaitre Vascular is a provider of devices and implants for the treatment of peripheral vascular disease, a condition that affects more than 20 million people worldwide. The Company develops, manufactures and markets disposable and implantable vascular devices to address the needs of its core customer, the vascular surgeon. The Company's diversified product portfolio consists of brand name devices used in arteries and veins outside of the heart. Additional information can be found at http://www.lemaitre.com.

LeMaitre and the LeMaitre Vascular logo are registered trademarks of LeMaitre Vascular, Inc.